Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Kainos Laboratories Inc. (4556:JPX), powered by AI.
Kainos Laboratories Inc. is currently trading at ¥2,268. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Kainos Laboratories Inc. on Alpha Lenz.
Kainos Laboratories Inc.'s P/E ratio is 14.9.
“Kainos Laboratories Inc. trades at a P/E of 14.9 (undervalued) with solid ROE of 9.8%.”
Ask for details →Kainos Laboratories Inc. is a biotechnology company engaged in the research, development, and commercialization of innovative diagnostic solutions. The primary function of Kainos Laboratories is to enhance healthcare outcomes through advanced diagnostic tools, which are pivotal in early detection and disease management. Specializing in clinical diagnostics and laboratory instruments, the company serves a diverse array of sectors, including healthcare institutions, research facilities, and pharmaceutical companies. With a focus on delivering precise and reliable testing equipment, Kainos Laboratories supports both private and public healthcare systems, contributing significantly to the efficacy of health monitoring and disease prevention strategies. The company's technological advancements and commitment to quality have established it as a reputable entity within the biotech industry, highlighting its role in improving global healthcare standards.
“Kainos Laboratories Inc. trades at a P/E of 14.9 (undervalued) with solid ROE of 9.8%.”
Ask for details →Kainos Laboratories Inc. (ticker: 4556) is a company listed on JPX in the Healthcare sector (Medical Instruments & Supplies). It has approximately 133 employees. Market cap is $9.6B.
The current price is 2,268 with a P/E ratio of 14.92x and P/B of 1.41x.
ROE is 9.83% and operating margin is 15.52%. Annual revenue is $5.3B.